Castilho Á, Madsen E, Ambrósio AF, Veruki ML, Hartveit E. Diabetic hyperglycemia reduces Ca 2ϩ permeability of extrasynaptic AMPA receptors in AII amacrine cells. J Neurophysiol 114: 1545-1553 , 2015 . First published July 8, 2015 doi:10.1152/jn.00295.2015.-There is increasing evidence that diabetic retinopathy is a primary neuropathological disorder that precedes the microvascular pathology associated with later stages of the disease. Recently, we found evidence for altered functional properties of synaptic ␣-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in A17, but not AII, amacrine cells in the mammalian retina, and the observed changes were consistent with an upregulation of the GluA2 subunit, a key determinant of functional properties of AMPA receptors, including Ca 2ϩ permeability and current-voltage (I-V) rectification properties. Here, we have investigated functional changes of extrasynaptic AMPA receptors in AII amacrine cells evoked by diabetes. With patch-clamp recording of nucleated patches from retinal slices, we measured Ca 2ϩ permeability and I-V rectification in rats with ϳ3 wk of streptozotocin-induced diabetes and age-matched, noninjected controls. Under bi-ionic conditions (extracellular Ca 2ϩ concentration ϭ 30 mM, intracellular Cs ϩ concentration ϭ 171 mM), the reversal potential (E rev ) of AMPA-evoked currents indicated a significant reduction of Ca 2ϩ permeability in diabetic animals [E rev ϭ Ϫ17.7 mV, relative permeability of Ca 2ϩ compared with Cs ϩ (P Ca /P Cs ) ϭ 1.39] compared with normal animals (E rev ϭ Ϫ7.7 mV, P Ca /P Cs ϭ 2.35). Insulin treatment prevented the reduction of Ca 2ϩ permeability. I-V rectification was examined by calculating a rectification index (RI) as the ratio of the AMPA-evoked conductance at ϩ40 and Ϫ60 mV. The degree of inward rectification in patches from diabetic animals (RI ϭ 0.48) was significantly reduced compared with that in normal animals (RI ϭ 0.30). These results suggest that diabetes evokes a change in the functional properties of extrasynaptic AMPA receptors of AII amacrine cells. These changes could be representative for extrasynaptic AMPA receptors elsewhere in AII amacrine cells and suggest that synaptic and extrasynaptic AMPA receptors are differentially regulated.
DIABETIC RETINOPATHY IS BOTH the most common cause of legal blindness in working-age adults (reviewed by Gardner et al. 2011 ) and one of the most common complications of diabetes mellitus (henceforth referred to as diabetes). Although traditionally considered a microvascular disease, there is increasing evidence that diabetic retinopathy partially involves a dysfunction of the neural retina that precedes the microvascular pathology typically observed at later stages of the disease (Antonetti et al. 2006; Simó and Hernández 2014) . Supporting the hypothesis that prevascular diabetic retinopathy could be a primary neuropathological disorder is the accumulating evidence for diabetes-evoked changes in the functional state of specific neurotransmitter systems, with changes in expression and regulation of amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor subunits being subject to detailed investigations (Castilho et al. 2012; Gowda et al. 2011; Ng et al. 2004; Santiago et al. 2006 Santiago et al. , 2008 Semkova et al. 2010) . Of particular interest is the GluA2 subunit, which plays a crucial role in determining important functional properties of AMPA receptors, such as Ca 2ϩ permeability, current-voltage (I-V) rectification, single-channel conductance, and kinetics (reviewed by Cull-Candy et al. 2006; Greger and Esteban 2007; Traynelis et al. 2010) . Exposing retinal cultures enriched in amacrine cells to elevated glucose concentration induces a reduction in agonist-evoked Ca 2ϩ responses mediated by Ca 2ϩ -permeable AMPA receptors, most likely caused by a concomitant increase in the expression of the GluA2 subunit (Santiago et al. 2006) . It is difficult to directly measure the Ca 2ϩ permeability of AMPA receptors in intact systems, however, and changes in this important functional property are typically inferred indirectly by measuring changes in subunit expression or correlated changes in electrophysiological properties.
Recently, our laboratory used an experimental model of diabetes in mature rats to study synaptic transmission in the rod bipolar microcircuit and examined how diabetes differentially affects the functional properties of synaptic AMPA receptors expressed by AII and A17 amacrine cells, two important and well-characterized types of rod amacrine cells in the mammalian retina (Castilho et al. 2015) . The AII and A17 amacrine cells are postsynaptic to glutamatergic rod bipolar cells at dyad synapses (Kolb and Famiglietti 1974; Raviola and Dacheux 1987) , and there is evidence that Ca 2ϩ -permeable AMPA receptors are involved in mediating synaptic input from rod bipolar cells to both types of amacrine cells (Chávez et al. 2006; Osswald et al. 2007; Singer and Diamond 2003) . Whereas the A17 amacrine cell provides a GABAergic reciprocal inhibitory synapse back onto the rod bipolar cell (Nelson and Kolb 1985; Raviola and Dacheux 1987) , the AII amacrine cell outputs its signal to ON-cone bipolar cells via electrical synapses (Kolb and Famiglietti 1974; McGuire et al. 1984; Strettoi et al. 1992 Strettoi et al. , 1994 and to OFF-cone bipolar cells via inhibitory, glycinergic synapses (Pourcho and Goebel 1985; Sassoè-Pognetto et al. 1994; Strettoi et al. 1992 Strettoi et al. , 1994 . In addition to the glutamatergic input from rod bipolar cells at the arboreal dendrites, AII amacrine cells also receive glutamatergic input from some types of OFF-cone bipolar cells at the lobular appendages (Kolb and Famiglietti 1974; Strettoi et al. 1992; Veruki et al. 2003) . The main result of our laboratory's recent study was that diabetes evoked changes in the functional properties of synaptic AMPA receptors of A17 amacrine cells, including reduced Ca 2ϩ responses mediated by Ca 2ϩ -permeable AMPA receptors, and the observed changes were consistent with an upregulation of the GluA2 subunit (Castilho et al. 2015) . We did not find evidence for similar changes of synaptic AMPA receptors in AII amacrine cells.
There is evidence, however, that AII amacrine cells express extrasynaptic AMPA receptors with relatively high Ca 2ϩ permeability at their somata (Mørkve et al. 2002) , leaving open the possibility that diabetes might change extrasynaptic AMPA receptors on these cells which would not have been detected in our laboratory's previous study of synaptic receptors. On this basis, we decided to investigate whether experimentally induced diabetes alters functional properties of somatic extrasynaptic AMPA receptors of AII amacrine cells. We were particularly interested in potential changes of Ca 2ϩ permeability, which is of particular importance for neuronal signaling and plasticity (Higley and Sabatini 2012) . We recorded from nucleated patches isolated from AII amacrine cells and measured the relative Ca 2ϩ permeability (under bi-ionic conditions) and the I-V rectification properties of the AMPA receptors. Here, we find that diabetes reduces both Ca 2ϩ permeability and I-V inward rectification of extrasynaptic AMPA receptors in AII amacrine cells, suggesting that diabetes differentially regulates synaptic and extrasynaptic AMPA receptors in these cells.
METHODS
Retinal slice preparation. General aspects of the methods have previously been described in detail (Hartveit 1996; Mørkve et al. 2002) . Female albino rats (Wistar HanTac; 5-8 wk postnatal) were deeply anesthetized with isoflurane in oxygen and killed by cervical dislocation (procedure approved under the surveillance of the Norwegian Animal Research Authority). Vertical retinal slices were visualized (Axioskop 2 FS, Zeiss) with a ϫ40 water immersion objective (0.9 NA; Olympus) and infrared differential interference contrast videomicroscopy. Recordings were carried out at room temperature (22-25°C).
Solutions and drug application. The standard extracellular perfusing solution was continuously bubbled with 95% O 2 /5% CO 2 and had the following composition (in mM): 125 NaCl, 25 NaHCO 3 , 2.5 KCl, 2.5 CaCl 2 , 1 MgCl 2 , 10 glucose, pH 7.4. In recordings designed to measure the relative Ca 2ϩ permeability of AMPA receptor channels, recording pipettes were filled with an intracellular solution of the following composition (in mM): 150 CsCl, 5 HEPES, 2 MgATP and 10 EGTA. The pH was adjusted to 7.3 with CsOH, increasing the total Cs ϩ concentration to 171 mM. The osmolality of this intracellular solution was ϳ290 mosmol/kgH 2 O. In recordings designed to measure the I-V rectification properties, the pipettes were filled with an intracellular solution of the following composition (in mM): 125 CsCH 3 SO 3 , 15 TEA-Cl, 8 NaCl, 10 HEPES, 1 CaCl 2 , 4 MgATP and 5 EGTA. Spermine (Research Biochemicals International, Natick, MA) was added at a concentration of 100 M, Lucifer yellow (Sigma-Aldrich) was added at a concentration of 1 mg/ml, and pH was adjusted to 7.3 with CsOH. The osmolality of this intracellular solution was ϳ315 mosmol/kgH 2 O. The data acquisition software (PatchMaster; HEKA Elektronik, Lambrecht/Pfalz, Germany) corrected all holding potentials for liquid junction potentials on-line.
Theoretical liquid junction potentials were calculated with JPCalcW (Axon Instruments, Union City, CA).
In experiments for measuring Ca 2ϩ permeability of AMPA receptor channels in nucleated patches, S-AMPA (termed "AMPA" for simplicity; 1.6 mM; Tocris Bioscience, Bristol, UK) was applied from a theta-tube application pipette (nominal septum thickness ϳ117 m; final tip diameter 250 -300 m; Hilgenberg, Malsfeld, Germany). The pipette tip with the nucleated patch was positioned near the interface between control solution and agonist-containing solution continuously flowing out of each barrel, about 100 m downstream from the tip of the application pipette. The solution flow rate (5 ml/h) was maintained by syringe pumps (KDS220; KD Scientific, Boston, MA) controlled by the PatchMaster software. Concentration jumps of agonist to a nucleated patch were applied by rapidly moving the position of the application pipette and thus the solution interface while the recording pipette remained still. Agonist pulses were applied every 4 s. The application pipette was mounted on a piezo actuator (LSS-3100/PZS-100HS; Burleigh Instruments, Fishers, NY) operated by an amplifier (PZ-150M; Burleigh Instruments) stimulated with square-wave voltage pulses from the ITC-16 interface built into the recording amplifier (see below). Before being fed to the amplifier, the voltage pulses were smoothened by an electronic circuit consisting of an RC-filter (time constant 1 ms) and an inductive element to counteract oscillations. The 10 -90% solution exchange time (ϳ250 -300 s) was measured as the change in liquid junction current of an open patch pipette filled with 0.9% NaCl when moved from a solution of 0.9% NaCl to a solution of 0.09% NaCl. However, for a nucleated patch, the measured exchange time represents an underestimation of the true exchange time. To establish bi-ionic conditions during measurements of Ca 2ϩ permeability, the nucleated patches were exposed to an extracellular solution containing (mM) 30 CaCl 2 , 100 N-methyl-D-glucamine, 10 HEPES and 25 glucose (pH adjusted to 7.4 with HCl). AMPA was dissolved in the same solution. For measurements of Ca 2ϩ permeability, the reference electrode (Ag-AgCl wire) was connected to the recording chamber via an electrolyte-agar bridge to avoid directly exposing the reference electrode to changes of the extracellular solution.
Electrophysiological recording and data acquisition. Patch pipettes were pulled from thick-walled borosilicate glass (outer diameter, 1.5 mm; inner diameter, 0.86 mm). The open-tip resistance of the pipettes ranged from 5 to 7 M⍀ when filled with intracellular solution. Voltage-clamp recordings were performed with an EPC9-dual amplifier (HEKA Elektronik) controlled by PatchMaster software. After establishing a G⍀-seal (initial seal resistance 2-25 G⍀), currents caused by the recording electrode capacitance (fast capacitative current; "C fast " function in PatchMaster) were automatically measured and neutralized by the amplifier. After breaking into the cell, currents caused by the cell membrane capacitance (slow capacitative current; "C slow " function in PatchMaster) were partially neutralized by the amplifier. To establish a nucleated patch recording, the pipette was slowly withdrawn after establishing the whole-cell recording configuration, while continuous light suction (ϳ50 mbar) was applied to the pipette. When a nucleated patch was successfully isolated, the reduced membrane capacitance resulted in capacitative current transients of the opposite polarity that were cancelled by re-adjustment of the C slow neutralization circuitry. The sampling interval was set to 50 s, and, before sampling, signals were low-pass filtered (analog 3-and 4-pole Bessel filters in series) with a corner frequency (Ϫ3 dB) of 4 kHz.
Experimental model of type 1 diabetes. As in our laboratory's previous study (Castilho et al. 2015) , diabetes was induced in 4-wkold rats with a single intraperitoneal injection of streptozotocin (65 mg/kg body wt), a toxin that kills ␤-cells of the pancreatic islets of Langerhans (Lenzen 2008) . Animals used for control experiments did not receive any injections. Streptozotocin was stored at Ϫ20°C until the day of injection when it was dissolved in 10 mM Na-citrate buffer (pH 4.5). After injection, each rat was returned to its home cage and tested for development of diabetes by measuring the blood glucose concentration 2 days later. Blood glucose was measured with a hand-held glucometer (Contour Glucometer, Bayer) by collecting a drop of blood from the tail. The highest concentration we could measure with our glucometer was 600 mg/dl. Rats with blood glucose concentration exceeding 250 mg/dl were considered diabetic. At the day of the experiment, diabetes was again verified by measuring blood glucose. Animals with diabetes were used for electrophysiological experiments 22 Ϯ 0.8 days (range 18 -26 days) after injection with streptozotocin. At the time of the experiments, the diabetic animals were between 6 and 8 wk of age, and the control animals were between 5 and 7 wk of age. All animals were kept on a 12:12-h light-dark cycle with free access to food and water.
When rats received treatment with insulin (Sigma-Aldrich), diabetes was first verified by measuring blood glucose 2 days after streptozotocin injection, and then insulin was administered subcutaneously twice every day until the day of the experiment. During the first 2 days of insulin treatment, glucose concentration was measured twice daily, and the dose of insulin was adjusted between two and seven units to maintain the blood glucose concentration lower than 250 mg/dl. After the 3rd day of insulin treatment, we found that administration of six units of insulin twice each day resulted in adequate glucose levels, and this treatment continued without further adjustments until the day of the experiment. During this period, blood glucose concentration was measured once daily, before the second injection of insulin.
General data analysis. Data were analyzed with FitMaster (HEKA Elektronik), IGOR Pro (WaveMetrics, Lake Oswego, OR), AxoGraph X (AxoGraph Scientific, Sydney, Australia), Excel (Microsoft, Redmond, WA) and GraphPad Prism (GraphPad Software, La Jolla, CA). The peak amplitude of AMPA-evoked currents was measured as the mean amplitude between two vertical cursors positioned close to the peak current response as identified by eye. Data points of I-V relationships were fitted by third-to sixth-order polynomial functions. The order of the polynomial function was kept as low as possible while still getting a good fit as determined by eye. Reversal potentials (E rev ) were determined by the intersection of the fitted line with the abscissa. As a verification, we also measured the E rev by fitting a line to the two data points closest to the presumed E rev (i.e., the lowest amplitude inward and outward currents). The results were very similar to those obtained by fitting all data points with polynomial functions. To quantify the degree of rectification of I-V relationships, we used the following equation to calculate a rectification index (RI) that expresses the ratio of chord conductance at ϩ40 mV and Ϫ60 mV (RI ϭ G ϩ40 /G Ϫ60 ): (1) where I ϩ40 and I Ϫ60 are the currents at ϩ40 mV and Ϫ60 mV, respectively, and E rev is in mV. Data are presented as means Ϯ SE (n ϭ number of cells). Statistical analysis with comparisons between two groups (normal, diabetes) were performed using Student's twotailed t-test (unpaired), and comparisons between three groups (normal, diabetes, insulin-treated diabetes) were performed using analysis of variance (ANOVA), followed by Tukey's multiple comparison procedure to obtain adjusted P values. Differences were considered statistically significant at the P Ͻ 0.05 level. The number of individual traces included in the averaged traces in the figures is stated for each case. For illustration purposes, most raw data records were low-pass filtered (digital nonlagging Gaussian filter, Ϫ3 dB at 500 Hz to 2 kHz). (Iino et al. 1990; Jonas and Sakmann 1992) . E rev was determined from currents evoked by application of AMPA at a series of holding potentials. The relative permeability of Ca 2ϩ compared with Cs ϩ (P Ca /P Cs ) was subsequently calculated from the following equation derived from the Goldman-Hodgkin-Katz constant-field equation (Iino et al. 1990 ):
where F is Faraday's constant, R is the universal gas constant, T is the absolute temperature, P Ca 
RESULTS

Identification of AII amacrine cells in retinal slices and isolation of nucleated patches.
In recordings designed to estimate the relative Ca 2ϩ permeability of AMPA receptors in nucleated patches from AII amacrine cells, it was not possible to verify the identity of the recorded cells with fluorescence microscopy because the requirement for bi-ionic conditions excluded the addition of Lucifer yellow to the intracellular solution. Considerable care was therefore taken to target cells that displayed the complete morphological characteristics of AII amacrines, as judged by the appearance of retinal slices imaged with infrared differential interference contrast videomicroscopy ( Fig. 1A) . Specifically, the criteria were the location of the cell body at the border of the inner nuclear layer and the inner plexiform layer and the presence of a thick apical dendrite descending into the inner plexiform layer. In addition, immediately following the establishment of the whole cell configuration, we verified that 5-mV depolarizing test pulses (5-ms duration) from a holding potential of Ϫ60 mV evoked the characteristic inward action currents corresponding to unclamped action potentials (Fig. 1B) that depend on tetrodotoxin-sensitive voltage-gated Na ϩ channels (Mørkve et al. 2002; Veruki et al. 2003) . In previous studies, our laboratory has found that all cells visually targeted by the above criteria that also subsequently display the characteristic action currents can be positively identified as AII amacrine cells when examined with fluorescence microscopy (Mørkve et al. 2002; Veruki et al. 2003) . Only cells that satisfied these selection criteria have been included in the material reported here. In recordings from nucleated patches where the goal was to study I-V rectification properties, Lucifer yellow was added to the intracellular solution, and fluorescence microscopy could be used to verify the identity of the cells from which we recorded.
For our study, we used a total of nine normal, eight diabetic, and three insulin-treated rats. For the rats injected with streptozotocin, the blood glucose concentration ranged from 290 to Ն600 mg/dl 2 days after injection and from 537 to Ն600 mg/dl at the day of the experiment. Before injection, the blood glucose in these rats was 89 Ϯ 3 mg/dl (range 76 -101 mg/dl), similar to the concentration measured in four normal controls tested at the day of the experiment (82 Ϯ 6 mg/dl; range 67-94 mg/dl).
AMPA-evoked currents in nucleated patches. Nucleated patches (Fig. 1C) voltage-clamped at Ϫ60 mV were transiently exposed to AMPA (1.6 mM) using a theta-tube fast-application system. In all cases, the nucleated patches responded with an inward current that rose to a peak, followed by an exponential decay to a much smaller steady-state level during sustained agonist application (Fig. 1D) , corresponding to rapid and strong desensitization (Mørkve et al. 2002; Veruki et al. 2003) . Previous work indicates that the receptors mediating the response to AMPA are high-affinity AMPA/low-affinity kainate receptors, as opposed to high-affinity kainate/low-affinity AMPA receptors (Mørkve et al. 2002) . Figure 2 , A and B, shows an example of responses evoked by AMPA (1.6 mM) at a series of holding potentials, together with the corresponding I-V curve for the peak response (E rev ϭ Ϫ4.0 mV). Because the steady-state response component in some patches was too small for accurate measurement, it was not used for analysis. The average E rev for nucleated patches isolated from normal animals was Ϫ7.7 Ϯ 0.9 mV ( Fig. 2E ; range Ϫ11.3 to Ϫ4.0 mV; n ϭ 7 patches). From these values, the permeability ratio (P Ca /P Cs ) of the AMPA receptors expressed in the cell bodies of AII amacrines was calculated according to Eq. 2, yielding an average value of 2.35 Ϯ 0.11 (range 1.92-2.89). These results are very similar to those reported in the earlier study by Mørkve et al. (2002) (E rev ϭ Ϫ10.7 Ϯ 1.8 mV; P Ca /P Cs ϭ 2.1 Ϯ 0.21).
Nucleated patches isolated from AII amacrine cells from diabetic animals were investigated identically to nucleated patches from normal animals. Figure 2 , C and D, shows an example of responses evoked by AMPA (1.6 mM) at a series of holding potentials, together with the corresponding I-V relationship (E rev ϭ Ϫ13.7 mV). The average E rev for AMPAevoked responses in nucleated patches isolated from diabetic rats was Ϫ17.7 Ϯ 1.8 mV ( Fig. 2E ; range Ϫ32.4 to Ϫ13.1 mV; n ϭ 11 patches). The corresponding permeability ratio (P Ca / P Cs ) was 1.39 Ϯ 0.1 (range 0.65-1.74), significantly lower than the corresponding ratio in patches from normal rats [ Fig. 3C ; F (2,20) ϭ 25.12, P Ͻ 0.0001, one-way ANOVA followed by Tukey's post hoc test]. This change corresponds to a reduction in the Ca 2ϩ permeability of the AMPA receptor channels of AII amacrine cells in diabetic animals and suggests a change in the subunit composition of the AMPA receptors.
Insulin treatment of diabetic rats prevents the reduced Ca 2ϩ
permeability of AMPA receptor channels in nucleated patches. If hyperglycemia is causally related to the reduced Ca 2ϩ permeability observed in nucleated patches from AII amacrines in diabetic rats, it should be possible to prevent the reduction by maintaining normoglycemia with insulin treatment. To investigate this, we injected 4-wk-old rats with streptozotocin in the same way as described earlier, verified the development of hyperglycemia 2 days after injection and then started treatment with insulin. After a period of 15-17 days with insulin treatment, nucleated patches were isolated from AII amacrines and tested with application of AMPA in the same way as described above. Figure 3 , A and B, shows an example of responses evoked by AMPA at a series of holding potentials, together with the corresponding I-V relationship (E rev ϭ Ϫ8.8 mV). The average E rev for AMPA-evoked responses in nucleated patches isolated from diabetic rats treated with insulin was Ϫ9.1 Ϯ 0.5 mV ( Fig. 2E ; range Ϫ10.9 to Ϫ8.2 mV; n ϭ 5 patches). The corresponding permeability ratio (P Ca /P Cs ) was 2.17 Ϯ 0.06 (range 1.96 -2.28), significantly different from diabetic rats that were not treated with insulin [ Fig. 3C ; F (2,20) ϭ 25.12, P ϭ 0.0003, one-way ANOVA followed by Tukey's post hoc test], but not significantly different from normal animals [F (2,20) ϭ 25.12, P ϭ 0.567, one-way ANOVA followed by Tukey's post hoc test]. This indicated that insulin treatment was able to prevent the diabetes-evoked reduction in the Ca 2ϩ permeability of the AMPA receptors of AII amacrine cells, suggesting that the associated hyperglycemia could be causally involved. 
Current-voltage relationships of AMPA-evoked currents in Na
ϩ -rich external solution. The subunit composition of an AMPA receptor determines not only Ca 2ϩ permeability, but also other functional properties, like single-channel conductance, kinetics and I-V rectification (for review, see Greger and Esteban 2007) . To investigate the rectification properties of AMPA receptors in AII amacrine cells, we used a Na ϩ -rich external solution. Because intracellular polyamines are important for the rectification properties of certain types of non-Nmethyl-D-aspartate (NMDA) receptor channels (Kamboj et al. 1995; Koh et al. 1995) , we added spermine (100 M) to the pipette solution to prevent washout of intracellular polyamines from being a confounding factor. Figure 4A shows an example of nucleated patch responses evoked by AMPA (1.6 mM) at a series of holding potentials, with the patch taken from a normal animal. The corresponding I-V relationship for the peak response displays clear inward rectification (Fig. 4B) . We calculated the RI as the ratio between the chord conductances at ϩ40 mV and Ϫ60 mV according to Eq. 1. For the nucleated patch illustrated in Fig. 4, A and B, we found E rev ϭ Ϫ1.7 mV and RI ϭ 0.27. For all nucleated patches from normal animals, the average values were 0.51 Ϯ 2.70 mV (range Ϫ11.8 to 12.6 mV) for E rev and 0.30 Ϯ 0.02 (range 0.23-0.44) for RI (n ϭ 9 patches; Fig. 4E ). Next, we performed similar experiments with diabetic animals (2-3 wk after the induction of diabetes). Figure 4C shows an example of nucleated patch responses evoked by AMPA (1.6 mM) at a series of holding potentials, with the patch taken from a diabetic animal. The corresponding I-V relationship for the peak response displays inward rectification (Fig. 4D) . For this patch, we found E rev ϭ 6.4 mV and RI ϭ 0.39. For all nucleated patches from diabetic animals, the average values were 7.7 Ϯ 3.9 mV (range Ϫ8.4 to 29.2 mV) for E rev and 0.48 Ϯ 0.07 (range 0.27-0.89) for RI (n ϭ 10 patches; Fig. 4E ). The average RI was significantly higher than that from normal rats (P ϭ 0.04; unpaired t-test), reflecting a measurable decrease in inward rectification.
DISCUSSION
Here we have studied the effect of diabetes on functional properties of extrasynaptic AMPA-type glutamate receptors on the cell bodies of AII amacrine cells in the rat retina. Specifically, we used electrophysiological recording from nucleated patches to measure the relative Ca 2ϩ permeability and I-V rectification of these receptors. Our major finding is that diabetes evokes both a decrease in Ca 2ϩ permeability and a decrease in inward rectification of the I-V relationship. The most parsimonious interpretation of these results is that diabe- . C: responses evoked by application of 1.6 mM AMPA (400 ms) to a nucleated patch from a rat with experimental diabetes under bi-ionic conditions (same recording conditions as A). Each trace is the average of five trials. D: I-V relationship of peak responses of nucleated patch in C (fitted with a 4th-order polynomial function). E: reversal potentials of AMPAevoked currents (here and below, bars represent means Ϯ SE) in nucleated patches from AII amacrine cells from normal animals (n ϭ 7 patches), diabetic animals (n ϭ 11 patches) and insulin-treated diabetic animals (n ϭ 5 patches). Here and below, data from individual recordings are represented by circles. Here and below, the results from statistical comparisons between averages are indicated by ns (no significant difference; P Ն 0.05) or a single asterisk (statistically significant difference; P Ͻ 0.05).
tes leads to a change in the subunit composition of the somatic extrasynaptic AMPA receptors of AII amacrine cells, most likely corresponding to an upregulation and increased content of the GluA2 subunit. These results raise a series of questions with respect to the relation between synaptic and extrasynaptic AMPA receptors of AII amacrine cells, how each might be influenced by diabetes and what the functional consequences of such changes could be.
Functional properties of synaptic and extrasynaptic AMPA receptors expressed by AII amacrine cells. Morphological investigations have not demonstrated synaptic input from rod or cone bipolar cells to the cell bodies of AII amacrine cells (e.g., Strettoi et al. 1992) . Nevertheless, electrophysiological recordings from nucleated patches of AII amacrine cells have demonstrated the presence of non-NMDA-type ionotropic glutamate receptors with relatively high Ca 2ϩ permeability and moderate inward rectification, and pharmacological analysis indicated the expression of AMPA, but not kainate receptors (Mørkve et al. 2002) . Furthermore, ultrafast application of glutamate to somatic outside-out patches from AII amacrine cells evokes strongly desensitizing responses with very fast deactivation and desensitization kinetics (Veruki et al. 2003 ).
These results suggest the expression of AMPA receptors with relatively low levels of the GluA2 subunit. The receptors examined in somatic patches are most definitely extrasynaptic receptors, raising the question of how similar they are to the synaptic receptors which mediate input from rod bipolar cells at the arboreal dendrites and OFF-cone bipolar cells at the lobular appendages. Both the kinetic and pharmacological properties of synaptic non-NMDA receptors, as studied by electrophysiological recording of spontaneous excitatory postsynaptic currents (spEPSCs), suggest a strong degree of similarity with the somatic extrasynaptic receptors (Veruki et al. 2003 ), but there is less direct evidence for high Ca 2ϩ permeability of the synaptic AMPA receptors of AII amacrine cells. First, paired recordings of synaptically coupled rod bipolar cells and AII amacrine cells indicate moderate inward I-V rectification, suggesting expression of Ca 2ϩ -permeable receptors (Singer and Diamond 2003) . Second, stimulation with kainate evokes influx of Co 2ϩ through Ca 2ϩ -permeable AMPA receptors, and the pattern of Co 2ϩ accumulation suggests that the relevant receptors are located not only at the cell bodies of AII amacrines, but at dendritic processes as well (Osswald et al. 2007 ). Finally, immunocytochemical investigations have found evidence for the presence of GluA4 (and GluA3), but not GluA2, in synapses between rod bipolar cells and AII amacrine cells (Ghosh et al. 2001; Qin and Pourcho 1999) . To our knowledge, there are no published reports of corresponding functional and morphological data for the synapses between OFF-cone bipolar cells and AII amacrine cells. Taken together, these results suggest a high degree of similarity between the functional properties of extrasynaptic somatic AMPA receptors and synaptic AMPA receptors in AII amacrine cells. It is unknown, however, if the functional properties of the somatic AMPA receptors correspond to the functional properties of putative extrasynaptic AMPA receptors located at AII processes close to the synaptic inputs of rod bipolar and/or OFF-cone bipolar cells.
Diabetes-evoked changes of AMPA receptors of AII amacrine cells. We recently found evidence for diabetes-evoked changes of the functional properties of synaptic AMPA receptors in A17, but not AII amacrine cells in rat retina (Castilho et al. 2015) . The changes were observed by electrophysiological recording of spEPSCs and corresponded to a reduction in the single-channel conductance and altered pharmacological properties, consistent with an upregulation of the GluA2 subunit and reduced Ca 2ϩ permeability. In addition, two-photon imaging revealed reduced agonist-evoked influx of Ca 2ϩ in the dendritic varicosities of A17 amacrine cells from diabetic animals. There are at least three ways the results of the present study can be interpreted in light of the lack of any diabetesevoked functional changes of synaptic AMPA receptors of AII amacrines reported in our recent study (Castilho et al. 2015) . First, it is possible that the changes we have observed for somatic extrasynaptic AMPA receptors are predictive of similar changes occurring for extrasynaptic AMPA receptors located elsewhere in AII amacrine cells. This could mean that diabetes reduces the Ca 2ϩ permeability not only of somatic, but also of putative dendritic, extrasynaptic AMPA receptors. This possibility cannot be eliminated because changes of dendritic extrasynaptic receptors would not have been detected in our previous study with recording of spEPSCs. Second, despite the fact that we did not detect any physiological, pharmaco- Ca 2ϩ permeability relative to Cs ϩ permeability, P Ca /P Cs ) of AMPA receptor channels in nucleated patches from AII amacrines in normal animals (n ϭ 7 patches), diabetic animals (n ϭ 11 patches) and insulin-treated diabetic animals (n ϭ 5 patches). See Fig. 2 legend for definition of symbols. logical or biophysical differences between spEPSCs in AII amacrines of normal and diabetic animals (Castilho et al. 2015) , it is not possible to exclude the possibility that diabetes could reduce the Ca 2ϩ permeability of synaptic AMPA receptors in these cells, independent of any potential changes of dendritic extrasynaptic AMPA receptors. On the basis of established properties of Ca 2ϩ -permeable AMPA receptors (Cull-Candy et al. 2006) , it is unlikely that a change in Ca 2ϩ permeability would occur without concomitant changes in other functional properties, but without being able to directly measure the Ca 2ϩ permeability of the synaptic AMPA receptors, the possibility cannot be excluded. A complicating factor is that Ca 2ϩ -permeable AMPA receptors can be involved in mediating synaptic input from both OFF-cone bipolar cells at the lobular dendrites and from rod bipolar cells at the arboreal dendrites of AII amacrines, and receptors at the different synapses could be differentially regulated. If diabetes reduces the Ca 2ϩ permeability at either location of synaptic AMPA receptor by changing the receptor subunit composition, the change was not detected by our physiological, pharmacological and biophysical analysis. Although unlikely, it is difficult to completely rule out the possibility of a change in subunit composition that leads to a dissociation between Ca 2ϩ permeability and other physiological, pharmacological and biophysical properties. There is some evidence that these functional properties of AMPA receptors are not as closely correlated as originally believed, such that determination of one property does not necessitate expression of the other (reviewed by Bowie 2012) . The third interpretation of the present results is that the synaptic and extrasynaptic (somatic) AMPA receptors of AII amacrine cells are genuinely different, either with respect to their subunit composition, their posttranslational modification or with respect to their regulation and/or trafficking (Bowie 2012) .
It would be challenging to directly investigate the Ca 2ϩ permeability of synaptic AMPA receptors and how this property might change in different conditions. First, bi-ionic conditions as used in the present study cannot be adequately obtained with whole-cell recording, and outside-out patches cannot be isolated from postsynaptic sites at AII amacrine dendrites. Second, whereas it should be possible to detect changes of I-V rectification of evoked EPSCs with simultaneous dual recording of synaptically coupled pairs, either pairs of rod bipolar cells and AII amacrine cells or pairs of OFF-cone bipolar cells and AII amacrine cells, I-V rectification and Ca 2ϩ permeability might be dissociated as mentioned earlier (Bowie 2012) . Recording of synaptically coupled cell pairs is also unlikely to be adequate for detailed pharmacological analysis because synaptic release from bipolar cells runs down relatively quickly. Third, measuring Ca 2ϩ influx by a combination of two-photon imaging and microiontophoretic application of agonist to dendrites of AII amacrine cells, as we did for dendritic varicosities of A17 amacrine cells (Castilho et al. 2015) , can potentially provide valuable information, but cannot easily distinguish between synaptic and extrasynaptic receptors when applied to neurons in slice preparations. The technique of two-photon uncaging of neurotransmitter agonists has the high- est spatial resolution, but even in this case it is difficult to ensure that only synaptic AMPA receptors are activated. Functional consequences of diabetes-evoked changes of AMPA receptors in AII amacrine cells. In the present study, we have examined diabetes-evoked changes of somatic extrasynaptic receptors. Given the lack of synaptic input from bipolar cells to the cell bodies of AII amacrines, it is not known whether these extrasynaptic receptors would encounter a glutamate concentration sufficiently high for channel opening under normal conditions. However, there is evidence for elevated levels of glutamate both in the retina of animals with experimentally induced diabetes (Lieth et al. 1998 ) and in the vitreous of patients with proliferative diabetic retinopathy (Ambati et al. 1997) . Accumulation of glutamate in the extracellular space could be caused by reduction of glutamine synthetase in Müller cells, with consequent reduced conversion of glutamate to glutamine, by reduced oxidation of glutamate to ␣-ketoglutarate or by impaired uptake of glutamate by Müller cells (Li and Puro 2002; Lieth et al. 2000) .
If ambient glutamate evokes channel opening, it is possible that an increased concentration of ambient glutamate in the diabetic retina could lead to reduced input resistance and thus changes in the integrative properties of AII amacrines. Another possibility is that the level of ambient glutamate primarily evokes steady-state desensitization of the extrasynaptic AMPA receptors. The reduced Ca 2ϩ permeability of AMPA receptors observed here could be a mechanism for counteracting increased Ca 2ϩ influx evoked by increased extracellular glutamate in the diabetic retina. In effect, the reduced Ca 2ϩ permeability could be a protective mechanism rendering neurons less susceptible to glutamate excitotoxicity. At the moment, however, we do not know if the change in Ca 2ϩ permeability is caused indirectly, e.g., as a consequence of changes in extracellular glutamate, or if diabetes has a direct effect on different types of neurons and their expression of transmitter receptors.
It is not known whether the diabetes-evoked reduction of Ca 2ϩ permeability for somatic extrasynaptic AMPA receptors of AII amacrines also applies to putative extrasynaptic dendritic AMPA receptors and/or synaptic AMPA receptors. The fast kinetics of Ca 2ϩ -permeable AMPA receptors result in a very brief Ca 2ϩ influx through these receptors, but the functional consequences of the expression of such receptors at synaptic or extrasynaptic sites in AII amacrine cells is currently unclear. Recently, a model with a preferential location of Ca 2ϩ -permeable and Ca 2ϩ -impermeable AMPA receptors at synaptic and perisynaptic locations of bipolar cell inputs to retinal ganglion cells was postulated (Jones et al. 2014) . Varying the strength of presynaptic activation leads to differential activation of the different types of postsynaptic AMPA receptors, depending on the degree of spillout of glutamate at these synapses. If similar mechanisms are operative at the bipolar cell inputs to AII amacrines, changes in the Ca 2ϩ permeability of AMPA receptors evoked by diabetes could influence the signaling and integrative properties of AII amacrine cells, including the activity-driven intracellular Ca 2ϩ dynamics related to regulating the strength of gap junction-mediated electrical coupling between AII amacrine cells (Kothmann et al. 2009 (Kothmann et al. , 2012 which is likely to be an important mechanism for postreceptoral visual adaptation (reviewed by Demb 2010).
